Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Theralase launches Anti-Cancer Therapy Research Centre

<< Previous

Bullboard Posts

Next >>

Comment by langostaon Dec 26, 2021 6:49am

326 Views

Post# 34262606

RE:RE:RE:Theralase launches Anti-Cancer Therapy Research Centre

Would not a procedure which indicates the type of success below be much more newsworthy?

19,000, in one region. If they had all been successful I think that would have made front page headlines.

Fraser Health says people of all ages, particularly seniors at risk of complications from conventional surgery, are benefitting from interventional radiology. More than 19,000 interventional radiology procedures were done in the region last year, and demand appears to be growing, the health authority says.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023